Adcock Ingram’s turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.
High winter product demand lifts Adcock Ingram’s turnover
Original Article by Kabelo Khumalo | Business Day | 23 August 2024
Adcock Ingram's turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.